Serous Cystadenocarcinoma: Clinical Trials

2 trials for Serous Cystadenocarcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 unknown. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 21Active not recruiting 1

Follow Serous Cystadenocarcinoma: new trials by email Literature Review of Serous Cystadenocarcinoma trials Research Report on Serous Cystadenocarcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)7982017-01-302026-06-17
Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage
Uterine lavage, Blood sample, Uterine lavage catheter - Ovarian Cancer, Ovarian Carcinoma
Not applicableUnknownSheba Medical Center5002014-06-292020-02-26

Narrower conditions

Cystadenocarcinoma, Serous (2)  ·  Adenocarcinoma, Bronchiolo-Alveolar (1)  ·  Adenocarcinoma, Mucinous (1)  ·  Adrenocortical Carcinoma (1)  ·  Bile Duct Neoplasms (1)  ·  Carcinoma, Acinar Cell (1)  ·  Carcinoma, Adenoid Cystic (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Endometrioid (1)  ·  Carcinoma, Giant Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Carcinosarcoma (1)  ·  Cholangiocarcinoma (1)  ·  Chordoma (1)  ·  Cystadenocarcinoma, Mucinous (1)

Broader conditions

Adenocarcinoma (2)  ·  Adnexal Diseases (2)  ·  Carcinoma (2)  ·  Cystadenocarcinoma (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Gonadal Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)

Interventions

Blood Specimen Collection (1)  ·  CTLA-4 Antigen (1)  ·  Ipilimumab (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Nivolumab (1)  ·  Specimen Handling (1)

Sponsors

National Cancer Institute (NCI) (1)  ·  Sheba Medical Center (1)

Countries

Guam (1)  ·  Israel (1)  ·  United States (1)

Top investigators

Keren Levanon, MD,PhD (1)  ·  Ram Eitan, MD (1)  ·  Sandip P Patel (1)  ·  Yfat Kadan, MD (1)

Results publications

PMID 31969335, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 36214786, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790

NIH funding

U10CA180888 (1)